US Patent Issued to University of Miami on Feb. 3 for "Method of determining responsiveness to cell therapy in dilated cardiomyopathy" (Florida Inventor)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,540,357, issued on Feb. 3, was assigned to University of Miami (Miami).

"Method of determining responsiveness to cell therapy in dilated cardiomyopathy" was invented by Joshua M. Hare (Miami Beach, Fla.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed to methods for determining responsiveness to cell therapy in a subject suffering from a cardiovascular disorder (e.g., cardiomyopathy) and methods of treating subjects suffering from a cardiovascular disorder."

The patent was filed on Nov. 8, 2019, under Application No. 17/291,556.

*For further information, including images, charts and tables, please visit: http://patft.us...